MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image EVOMMUNE INC
EVOMMUNE INC

EVOMMUNE INC

HQ - Palo Alto

Summary

Evommune is a clinical-stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases.

Deals Overview

Total Deals1
Valued Deals1
Total Value£ 89 M
Avg. Deal Size£ 89 M

Market Context

Sort

31 Oct 2024|United States|Biotechnology
Evommune
SYMBIOSIS

Target: EVOMMUNE INC

Bidder: SYMBIOSIS

4 Service Providers

2 Target | 2 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 88 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite